Brought to you by 
Thoratec Laboratories acquires Thermo Cardiosystems
26 Oct 2001
Executive Summary
Thoratec Laboratories (circulatory support and vascular graft application devices) has acquired Thermo Electron's Thermo Cardiosystems (implantable left ventricular-assist systems (LVAS)) in a $695mm tax-free stock swap. Thermo Cardiosystems shareholders will receive 0.835 of a newly issued Thoratec share (valued at $18.02, a (pr)95% premium based on the market average) for each share they own. Thoratec will also assume $45mm in debt.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com